Clinical trials
Recruiting Phase 1/2 trials in Taiwan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
100 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 5 |
| 2022 | 12 |
| 2023 | 13 |
| 2024 | 27 |
| 2025 | 28 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 100 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 13 |
| AstraZeneca | 9 |
| Chang Gung Memorial Hospital | 3 |
| China Medical University Hospital | 3 |
| Janssen Research & Development, LLC | 3 |
| Novartis Pharmaceuticals | 3 |
| Pierre Fabre Medicament | 3 |
| Alentis Therapeutics AG | 2 |
| Anbogen Therapeutics, Inc. | 2 |
| BioNTech SE | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 22 |
| Neoplasms | 9 |
| Breast Neoplasms | 8 |
| Squamous Cell Carcinoma of Head and Neck | 8 |
| Carcinoma, Hepatocellular | 7 |
| Recurrence | 7 |
| Esophageal Squamous Cell Carcinoma | 6 |
| Colorectal Neoplasms | 5 |
| Neoplasm Metastasis | 5 |
| Endometrial Neoplasms | 4 |
Trials
Showing 1 to 25 of 100. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.